PRESS RELEASE published on 08/04/2025 at 10:50, 10 months 18 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA: Declaration of the number of shares and voting rights in the issued capital as of July 31, 2025 Voting Rights Déclaration Shares Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 08/04/2025 at 10:50, 10 months 18 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Déclaration du nombre d'actions et de droits de vote de Sartorius Stedim Biotech SA. Informations réglementaires du 04-Aou-2025 Déclaration Droits De Vote Capital Social Sartorius Stedim Biotech SA Réglementaire
BRIEF published on 07/22/2025 at 07:07, 11 months ago Sartorius Stedim Biotech Releases H1 2025 Financial Report Business Development Biopharmaceutical Industry Half-year Results Sartorius Stedim 2025 Financial Report
BRIEF published on 07/22/2025 at 07:07, 11 months ago Sartorius Stedim Biotech publie son rapport financier du premier semestre 2025 Résultats Semestriels Industrie Biopharmaceutique Développement Des Affaires Sartorius Stedim Rapport Financier 2025
BRIEF published on 07/22/2025 at 07:05, 11 months ago Sartorius Stedim Biotech annonce de solides résultats pour le premier semestre 2025 Rentabilité Sartorius Stedim Biotech Croissance Des Ventes Industrie Biopharmaceutique Résultats Semestriels 2025
BRIEF published on 07/22/2025 at 07:05, 11 months ago Sartorius Stedim Biotech Reports Solid Half-Year 2025 Results Profitability Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry Half-year Results 2025
PRESS RELEASE published on 07/22/2025 at 07:02, 11 months ago Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents Sartorius Stedim Biotech SA communique les résultats du premier semestre 2025 et les prévisions pour l'année 2025. Informations disponibles sur leur site Investor Relations Documents Résultats Premier Semestre Sartorius Stedim Biotech SA
PRESS RELEASE published on 07/22/2025 at 07:02, 11 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases first half 2025 results and full year forecast. Report available online with financial statements and company profile Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry First Half 2025 Results
PRESS RELEASE published on 07/22/2025 at 07:00, 11 months ago Résultats de Sartorius Stedim Biotech pour le premier semestre 2025 Résultats semestriels de Sartorius Stedim Biotech SA pour le premier semestre 2025: Chiffre d’affaires en hausse de 9,4%, EBITDA augmenté de 19,3% avec une marge de 31,0%. Prévisions confirmées pour l'année 2025 Chiffre D'affaires Résultats Semestriels EBITDA Sartorius Stedim Biotech Prévisions 2025
PRESS RELEASE published on 07/22/2025 at 07:00, 11 months ago Half-year results 2025 of Sartorius Stedim Biotech Sartorius Stedim Biotech reports strong half-year results for 2025 with sales revenue up 9.4% in constant currencies and underlying EBITDA rising by 19.3% Sartorius Stedim Biotech Sales Revenue Half-year Results 2025 Underlying EBITDA
Published on 06/22/2026 at 15:00, 39 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 1 hour 38 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 1 hour 39 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 14:00, 1 hour 39 minutes ago Loop Industries Appoints Institutional Shareholder Jeff Geygan to Board; GVIC Outlines Intent to Increase Ownership Stake to 10%
Published on 06/22/2026 at 15:28, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/22/2026 at 15:27, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/22/2026 at 15:25, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 06/22/2026 at 08:30, 7 hours 9 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 7 hours 9 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 20 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 20 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
